Saudi Central Bank »

Regeneron Pharmaceuticals shares owned by Saudi Central Bank

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Saudi Central Bank from 13F filings

Historical chart of Saudi Central Bank investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Saudi Central Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Saudi Central Bank

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.5M 7.3k 623.54
2026-03-31 $2.9M 3.8k 772.64
2025-03-31 $27k 43 634.23

More positions owned by Saudi Central Bank

Micron Technology (MU)
VanEck Semiconductor ETF Semiconductor Etf (SMH)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Apple (AAPL)
State Street Energy Select Sec St Str Energ Etf (XLE)
Microsoft Corporation (MSFT)
Invesco QQQ Trust Series 1 Unit Ser 1 (QQQ)
Advanced Micro Devices (AMD)
Vanguard Value ETF Value Etf (VTV)
Amazon (AMZN)
Palantir Technologies Cl A (PLTR)
State Street SPDR S&P 500 ETF Tr Unit (SPY)
State Street Technology Select St Str Techn Etf (XLK)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Saudi Central Bank

Top funds holding Regeneron Pharmaceuticals

BlackRock
Vanguard Capital Management
State Street Corporation
Dodge & Cox
Franklin Resources
Geode Capital Management
Invesco
T. Rowe Price Associates
Nuveen
Loomis, Sayles and
Wellington Management Company
Vanguard Portfolio Management
FMR
Goldman Sachs Group
Capital World Investors

View all funds holding Regeneron Pharmaceuticals